Atara Biotherapeutics Inc (ATRA NASDAQ) stock market data APIs
$13.4068
-0.41(-3.1%)
as of November 18, 2025
Try our APIs with
free plan!
Atara Biotherapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.
Prev. Close
13.4068
Open
12.9997
High
13.862
Low
12.6828
52 wk Range
5.005-18.705
Market Cap
97 050 K
P/E Ratio
4.7063
Shares Outstanding
7 210 K
Revenue
152 M
EPS
-0.32
Beta
-0.401
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Atara Biotherapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Atara Biotherapeutics Inc data using free add-ons & libraries
Get Atara Biotherapeutics Inc Fundamental Data
Atara Biotherapeutics Inc Fundamental data includes:
- Net Revenue: 152 M
- EBITDA: 44 852 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-30
- EPS/Forecast: -0.665
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Atara Biotherapeutics Inc News
New
Atara Biotherapeutics GAAP EPS of -$0.32 beats by $0.37, revenue of $3.5M beats by $0.76M
* Atara Biotherapeutics press release [https://seekingalpha.com/pr/20304068-atara-biotherapeutics-announces-third-quarter-financial-results-and-operational-progress] (ATRA [https://seekingalpha.com/...
Pacira (PCRX) Tops Q3 Earnings Estimates
Pacira (PCRX) came out with quarterly earnings of $0.7 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.79 per share a year ago. These figures are ad...
Adma Biologics (ADMA) Q3 Earnings Match Estimates
Adma Biologics (ADMA) came out with quarterly earnings of $0.16 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.15 per share a year ago. These figures are adjust...
5 Under-the-Radar Biotech Stocks That Could Soar in 2026
The biotech sector has long offered investors high-risk, high-reward stocks. While large players are making headlines, the next wave of breakthroughs may come from companies flying well below Wall Str...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
